This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Leucine-rich repeat-containing protein 25.
Plays also a role in the inhibition of NF-kappa-B signaling pathway and inflammatory response by promoting the degradation of p65/RELA. .
Human | |
---|---|
Gene Name: | LRRC25 |
Uniprot: | Q8N386 |
Entrez: | 126364 |
Belongs to: |
---|
No superfamily |
leucine rich repeat containing 25; leucine-rich repeat-containing protein 25; MAPAFLJ38116; monocyte and plasmacytoid activated molecule; Monocyte and plasmacytoid-activated protein
Mass (kDA):
33.179 kDA
Human | |
---|---|
Location: | 19p13.11 |
Sequence: | 19; NC_000019.10 (18391137..18397645, complement) |
Expressed in plasmacytoid dendritic cells (PDC), monocyte-derived dendritic cells (MDDC), granulocytes, monocytes, B-lymphocytes, peripheral blood leukocytes, spleen, bone marrow, and, to a lesser extent, lymph nodes, fetal liver, and appendix but not in thymus.
Membrane; Single-pass type I membrane protein. Cytoplasm.
PMID: 12384430 by Rissoan M.-C., et al. Subtractive hybridization reveals the expression of immunoglobulin like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells.
PMID: 29044191 by Feng Y., et al. LRRC25 functions as an inhibitor of NF-kappaB signaling pathway by promoting p65/RelA for autophagic degradation.